The results showed that when CNTFR was highly expressed in DLBCL, the survival rate of patients decreased (P < 0.05) (Figure 8D), which indicated that the changes in CNTFR had the potential adverse effects for the prognosis of DLBCL patients. This evidence concerns the gene CNTFR and diffuse large B-cell lymphoma.